Jacky Au

Jacky Au

Auto-generated profile, based on publicly available information

Jacky Au

University of California, Irvine

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2014 in Psychonomic Bulletin & Review
Verified
Journal Article
Closed access
PDF file
JAJacky Au
Jacky Au
ESEllen Sheehan
Ellen Sheehan
NTNancy Tsai
Nancy Tsai
GDGreg J. Duncan
Greg J. Duncan
MBMartin Buschkuehl
Martin Buschkuehl
SJSusanne M. Jaeggi
Susanne M. Jaeggi

30 October 2015 in Psychonomic Bulletin & Review
Verified
Journal Article
Closed access
PDF file
JAJacky Au
Jacky Au
MBMartin Buschkuehl
Martin Buschkuehl
GDGreg J. Duncan
Greg J. Duncan
SJSusanne M. Jaeggi
Susanne M. Jaeggi

29 January 2020 in Journal of Cognitive Enhancement
Verified
Journal Article
Closed access
PDF file
JAJacky Au
Jacky Au
BGBenjamin C. Gibson
Benjamin C. Gibson
KBKimberly Bunarjo
Kimberly Bunarjo
MBMartin Buschkuehl
Martin Buschkuehl
SJSusanne M. Jaeggi
Susanne M. Jaeggi

15 October 2011 in Human Genetics
Verified
Journal Article
Closed access
PDF file
WCWeerasak Chonchaiya
Weerasak Chonchaiya
JAJacky Au
Jacky Au
ASAndrea Schneider
Andrea Schneider
DHDavid Hessl
David Hessl
SHSusan W. Harris
Susan W. Harris
RHRandi J. Hagerman
Randi J. Hagerman

21 September 2011
Verified
Book Chapter
Closed access
PDF file
RHRandi Hagerman
Randi Hagerman
JLJulie Lauterborn
Julie Lauterborn
JAJacky Au
Jacky Au
EBElizabeth Berry-Kravis
Elizabeth Berry-Kravis

27 May 2011 in Journal of Neurodevelopmental Disorders
Verified
Journal Article
Open access
PDF file
RHRandi Hagerman
Randi Hagerman
JAJacky Au
Jacky Au
PHPaul Hagerman
Paul Hagerman
Fragile X syndrome (FXS) is caused by an expanded CGG repeat (>200 repeats) in the 5′ un-translated portion of the fragile X mental retardation 1 gene (FMR1) leading to a deficiency or absence of the FMR1 protein (FMRP). FMRP is an RNA-binding protein that regulates the translation of a number of other genes that are important for synaptic development and plasticity. Furthermore, many of these genes, when mutated, have been linked to autism in the general population, which may explain the high comorbidity that exists between FXS and autism spectrum disorders (ASD). Additionally, premutation repeat expansions (55 to 200 CGG repeats) may also give rise to ASD through a different molecular mechanism that involves a direct toxic effect of FMR1 mRNA. It is believed that RNA toxicity underlies much of the premutation-related involvement, including developmental concerns like autism, as well as neurodegenerative issues with aging such as the fragile X-associated tremor ataxia syndrome (FXTAS). RNA toxicity can also lead to mitochondrial dysfunction, which is common in older premutation carriers both with and without FXTAS. Many of the problems with cellular dysregulation in both premutation and full mutation neurons also parallel the cellular abnormalities that have been documented in idiopathic autism. Research regarding dysregulation of neurotransmitter systems caused by the lack of FMRP in FXS, including metabotropic glutamate receptor 1/5 (mGluR1/5) pathway and GABA pathways, has led to new targeted treatments for FXS. Preliminary evidence suggests that these new targeted treatments will also be beneficial in non-fragile X forms of autism.